|
News For MDT;BSX;MDT;JNJ;INTC;JNJ;INTC;VRTX;COV;VRTX;COV;BSX From The Last 14 Days Check below for free stories on MDT;BSX;MDT;JNJ;INTC;JNJ;INTC;VRTX;COV;VRTX;COV;BSX the last two weeks. |
|
|
| May 21, 2013 |
| 07:24 EDT |  | JNJ | Global Health Care to host a conference
 Subscribe for More Information |
|
| 07:19 EDT |  | MDT | Medtronic sees FY14 EPS $3.80-$3.85, consensus $3.84
Sees FY14 revenue growth up 3%-4% on a constant currency basis. |
|
| 07:17 EDT | | MDT | Medtronic reports Q4 EPS $1.10, consensus $1.03
Subscribe for More Information |
|
| 05:54 EDT |  | MDT | Medtronic announces primary results from Global Symplicity Registry
Subscribe for More Information |
|
| 05:51 EDT | | MDT | Medtronic CoreValue ADVANCE study shows low mortality rates
Subscribe for More Information |
|
| 05:48 EDT | | BSX | OrbusNeich seizes Boston Scientific stents as part of patent infringement case
Subscribe for More Information |
|
| May 20, 2013 |
| 15:22 EDT | | MDT | Notable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Home Depot (HD), consensus 77c; Medtronic (MDT), consensus $1.03; The TJX Companies (TJX), consensus 62c; AutoZone (AZO), consensus $7.23; Best Buy (BBY), consensus 25c; Dick's Sporting Goods (DKS), consensus 48c; Tidewater (TDW), consensus 61c; Saks (SKS), consensus 19c; Rexnord (RXN), consensus 31c; Monro Muffler Brake (MNRO), consensus 25c. |
|
| 09:41 EDT | | MDT, BSX | Supreme Court agrees to hear Medtronic-Boston Scientific patent case
Reported by SCOTUSblog live blog of court orders and opinions. |
|
| 08:10 EDT | | INTC | Intel management to meet with Deutsche Bank
Meeting to be held in Stockholm on May 20 hosted by Deutsche Bank. |
|
| 08:05 EDT | | COV | Covidien receives FDA 510(k) clearance for Nellcor pulse oximetry motion claims
Subscribe for More Information |
| |
| 07:32 EDT | | INTC | Society for Information Display / IHS to host a conference
Display Week 2013 is being held in Vancouver, British Columbia on May 19-24. |
|
| 07:32 EDT | | INTC | Society for Information Display / IHS to host a conference
Subscribe for More Information |
|
| 07:11 EDT | | MDT | Medtronic receives CE mark for 'export advance' aspiration catheter
Subscribe for More Information |
|
| May 19, 2013 |
| 18:59 EDT |  | INTC | Cisco looks the best out of tech comeback stocks, Barron's says
Cisco (CSCO), Intel (INTC), and Microsoft (MSFT) stocks have jumped this month, however, Intel and Microsoft's revenue growth declined, due to their reliance on the PC market, providing Cisco with an opportunity to pull ahead in the technology sector, Barron's contends in its Technology Trader column. Cisco looks moderately priced, the paper adds. Reference Link |
|
| May 17, 2013 |
| 06:19 EDT | | JNJ | J&J to end sales of of metal-on-metal hip replacements, Bloomberg reports
Subscribe for More Information |
|
| May 16, 2013 |
| 16:13 EDT | | BSX | Vascular Solutions files patent infringement complaint against Boston Scientific
Vascular Solutions (VASC) announced that it has filed a patent infringement complaint in the U.S. District Court for the District of Minnesota against Boston Scientific Corporation (BSX). The complaint alleges that Boston Scientific has infringed three patents owned by Vascular Solutions concerning rapid exchange guide extension technology by manufacturing and selling its Guidezilla guide extension catheter which received 510(k) clearance in March. Vascular Solutions is seeking an injunction against Boston Scientific prohibiting the manufacture and sale of its Guidezilla catheter as well as damages for lost profits and legal costs. |
|
| 13:40 EDT | | INTC | Intel CFO Smith says staying with the company, CNBC reports
Subscribe for More Information |
|
| 13:32 EDT |  | MDT | Medtronic volatility flat into Q4 and outlook
Subscribe for More Information |
|
| 10:03 EDT |  | MDT | On The Fly: Analyst Downgrade Summary
Subscribe for More Information |
|
| 07:51 EDT |  | BSX | Boston Scientific price target raised to $12 from $9 at JMP Securities
JMP Securities increased its price target on Boston Scientific as the firm believes after speaking with experts that S-ICD devices can be used in 50% of de novo implant cases, up from its previous estimate of 30%. The firm's FY13 and FY14 earnings estimates for the company are well above consensus levels and it reiterates an Outperform rating on the shares. |
| |
|
|
|
|
